IRulya Therapeutics IRLA
NASDAQ IRLA
$33.78 +2.78 (+8.95%)
At close: Nov 9, 2026 · 4:00 PM EST

IRulya Therapeutics (IRLA) Debt Ratio (2023 - 2025)

Updated

IRulya Therapeutics' (IRLA) Debt Ratio stood at 0.19 in Q4 2025, up 20.9% from the prior quarter.

Analysis

IRulya Therapeutics (IRLA) Debt Ratio (2023 - 2025) Analysis & Trends

Starting with Q4 2023, IRulya Therapeutics' Debt Ratio history includes 8 quarters.

  • Across earlier years, Debt Ratio came in at 0.08 in FY2023.
  • The Q4 2025 figure is the highest quarterly Debt Ratio in data going back to Q4 2023.
  • Per Business Quant, the preceding three quarters came in at 0.16 (Q3 2025), 0.14 (Q2 2025) and 0.14 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 0.33
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 0.23
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 0.55
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 0.41
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -0.10
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 0.56
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 0.51
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 0.31
10 IRulya Therapeutics 207.35 Mn 91.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 0.19
Sep 30, 2025 0.16
Jun 30, 2025 0.14
Mar 31, 2025 0.14
Dec 31, 2024 0.13
Sep 30, 2024 0.12
Jun 30, 2024 0.10
Mar 31, 2024 0.08
Dec 31, 2023 0.08
API Access

IRulya Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=IRLA&period=max&api_key=YOUR_API_KEY